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Abstract 
This paper explores whether the use of drug        
reviews and social media could be leveraged as        
potential alternative sources for    
pharmacovigilance of adverse drug reactions     
(ADRs). ​We examined the performance of BERT       
(​Devlin et al., 2018​) alongside two variants that        
are trained on biomedical papers, BioBERT      
(​Jinhyuk et al., 2019​), and clinical notes, Clinical        
BERT (​Alsentzer et al., 2019​). A variety of 8         
different BERT models were fine-tuned and      
compared across three different tasks in order to        
evaluate their relative performance to one another       
in the ADR tasks. The tasks include sentiment        
classification of drug reviews, presence of ADR       
in twitter postings, and named entity recognition       
of ADRs in twitter postings. ​BERT demonstrates       
its flexibility with high performance across all       
three different pharmacovigilance related tasks.  
1  Introduction 
Pharmacovigilance, the monitoring of potential     
harmful side effects in medications, plays a critical        
role in the healthcare system. Drug safety for        
patients is continually monitored and evaluated      
after they are released for commercial use.       
Although pharmaceutical companies evaluate drugs     
and their adverse drug reactions (ADRs) during       
clinical trials, the evaluation is limited to a        
relatively short duration, small sample sizes, and       
controlled settings. Once the drug is on the market,         
ADRs are typically reported to the Food and Drug         
Administration (FDA) through formal reports by      
patients, healthcare providers, and drug     
manufacturers. Relying on these mechanisms alone      
likely results in major underreporting of ADRs.  
For any type of medicine, there is an inherent         
trade-off between its benefit and potential for harm.        
It is essential for healthcare professionals and       
patients to be informed and understand the potential        
risks in order for them to make the best decision          
regarding the patients’ health and well-being. Drug       
reviews and social media can be leveraged for their         
quantity and expediency as potential alternative      
sources that could supplement and enhance the       
current system of post-market surveillance     
(​Alhuzali and Ananiadou, 2019​; ​Gräßer et al., 2018​;        
Xia et al., 2017​; ​Nikfarjam et al., 2015​). 
2  Background 
The field of natural language processing (NLP) has        
changed dramatically over the last few years.       
Embeddings from Language Models (ELMo) was      
introduced and quickly established itself as a       
breakthrough (​Peters et al., 2018​). It utilized Long        
Short Term Memory (LSTM) networks and was       
capable of creating word representations that      
utilized the entire sentence context. ELMo      
outperformed other models across many different      
natural language processing (NLP) benchmarks.     
Shortly thereafter, the Bidirectional Encoder     
Representations from Transformers (BERT) ​model     
was created (​Devlin et al., 2018​), which represented        
a further breakthrough in the field of NLP. This         
model has since become the state of the art for a           
variety of tasks and is created to take context from a           
sentence both forward and backwards. 
Since that time, the BERT model has been adapted         
to many different areas of research. In this paper,         
we examine the performance of BERT alongside       
two variants that are trained on biomedical data,        
BioBERT (​Jinhyuk et al., 2019​) and Clinical BERT        
(​Alsentzer et al., 2019​). BioBERT was trained on        
biomedical documents including PubMed abstracts     
as well as PubMed Central full text articles. Clinical         
BERT was trained on anonymized patient medical       
notes and patient discharge summaries. Because the       
description of ADRs deals specifically with medical       
terminology, the use of BERT models trained on        
medical or scientific corpora could result in an        
improvement when compared to the standard cased       
and uncased BERT models. 
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Previous work on sentiment and presence of ADR        
classification have used N-gram or word2vec      
approaches to create word vector representations      
and used Logistic Regression (LR), Naive Bayes       
(NB), or Support Vector Machines (SVM) as the        
classification model (​Gräßer et al., 2018​; ​Ginn et        
al., 2014​). Other approaches that used deep learning        
included LSTM or BiLSTM layers followed by a        
self-attention mechanism (​Alhuzali and Ananiadou,     
2019​). Results from these previous works had an        
accuracy of 92% for sentiment classification      
(​Gräßer et al., 2018​) and F-score of 0.845 for         
presence of ADR classification from twitter data       
(​Alhuzali and Ananiadou, 2019​). Conditional     
random fields (CRFs) was used in conjunction with        
K-means clustering on word2vec embeddings in a       
previous study for named entity recognition of       
adverse drug reactions and resulted in an F-score of         
0.721 on twitter data (​Nikfarjam et al., 2015​). In         
this paper, we aim to use the current state of the art            
techniques such as BERT to see if we can achieve          
improved performance. 
3  Methods 
We focused on three tasks related to       
pharmacovigilance which used two different     
datasets: 
1. Sentiment classification using the Drugs.com 
drug reviews dataset 
2. Presence of ADR classification using the 
Twitter dataset 
3. Name entity recognition (NER) detection of 
ADRs using a subset of the Twitter dataset 
A variety of 8 different BERT models were        
fine-tuned and compared across three different tasks       
in order to evaluate their relative performance to        
one another in the ADR tasks. The 8 BERT models          
consisted of BERT Cased (B-C), BERT Uncased       
(B-U), BioBERT 1.0 (BB-1.0), BioBERT 1.1      
(BB-1.1), Clinical BERT All Notes (CB-A),      
Clinical BERT Discharge (CB-D), Clinical     
BioBERT All Notes (CBB-A), and Clinical      
BioBERT Discharge (CBB-D). The authors of      
BERT have generally suggested that 2-4 epochs are        
the range for fine-tuning the model. ​The default        
parameters, max sequence length of 128, training       
batch size of 32, and learning rate of 2e-5, were          
used.   
The code used in this paper is located here:         
https://github.com/brentbiseda/w266_pro
ject 
3.1  Sentiment Classification 
Anonymized user reviews of drugs, their      
side-effects, and a quantitative user review score       
were collected from Drugs.com (​Gräßer et al.,       
2018​) ​and is found in the UCI machine learning         
repository. Our first task is sentiment classification       
of these user reviews based on the self-reported        
drug rating. The quantitative score allows for       
sentiment analysis by aggregating highly positive      
scores (8 or higher) to serve as a positive review,          
while highly negative scores are aggregated (3 or        
lower) and neutral scores (4-7) are aggregated as        
well. Therefore, we trained our sentiment classifier       
to discern between these three classes (Table 1). 
Dataset Positive Neutral Negative 
Training 
77,907 
(60.4%) 
23,114 
(17.9%) 
28,017 
(21.7%) 
Dev 
19,503 
(60.5%) 
5,710 
(17.7%) 
7,046 
(21.8%) 
Test 
32,349 
(60.2%) 
9,579 
(17.8%) 
11,838 
(22.0%) 
Table 1: Number of examples for the Drugs.com 
dataset  
We compared the test set accuracy across our set of          
8 different BERT variants. Besides the BERT       
Uncased model, all of the BERT models were        
trained with the cased configuration. In addition,       
four different baseline accuracies were established:      
the most common class, N-gram model with NB        
classifier, ELMo embeddings with LR, and      
pre-trained BERT Cased embeddings with LR. 
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3.2  Presence of ADR Classification 
The second task is detecting the presence of an         
ADR within a tweet. The Twitter dataset we used         
was collected, processed, and annotated by Arizona       
State University (​Ginn et al., 2014​). Because we        
used the Twitter API to retrieve the tweet text, and          
many of the tweets were no longer available, the         
dataset that we were able to use only contained         
4,169 examples, down from their 10,822 examples.       
Just like the original dataset, our dataset was        
heavily skewed towards tweets with no ADR       
presence. To try to combat the imbalance, we        
trained models using 3 variants of the training        
dataset (Table 2). The first training dataset is the         
original imbalanced dataset. The second training set       
has the positive class oversampled so that the two         
classes are balanced. The third training set has the         
negative class undersampled. The dev and test sets        
remained the same across the 3 variants. 
Dataset Im- 
balanced 
Over- 
sampled 
Under- 
sampled 
Training 
2501  
(11% 
positive) 
4440  
(50% 
positive) 
835 
(33% 
positive) 
Dev 834 
(11% positive) 
Test 834 
(11% positive) 
Table 2: Number of examples for the Twitter 
dataset  
For this task, B-C, B-U, and CBB-D models were         
fine tuned for 3 epochs for each training set. In          
addition to fine tuning, we extracted features from        
these models and used them to train an additional         
classifier. The first [CLS] token embeddings were       
used to train a LR model. All of the token          
embeddings were front-padded to the maximum      
token length and used to train convolutional neural        
network (CNN) and LSTM models. The most       
common class and N-gram with NB classifier were        
used as baseline models. 
3.3  Named Entity Recognition of ADRs 
The third task is detecting the beginning (B), inside         
(I), and outside (O) of a phrase containing an ADR          
related mention within a tweet. This task used a         
subset of the Arizona State University Twitter       
dataset. The subset consisted of 965 tweets in total,         
with 500 tweets that contained an ADR and 465         
examples that did not contain an ADR. Like any         
NER task, the large majority of the labels were O          
tags (Table 3). 
Dataset B I O 
Training  348 (2.8%) 345 (2.8%) 11627 (94.4%) 
Dev 88 (2.7%) 93 (2.9%) 3054 (94.4%) 
Test 160 (3.0%) 117 (2.2%) 5081 (94.8%) 
Table 3: Number of examples for the NER subset of 
the Twitter dataset 
The baseline models used for this task were the         
most common class and CRF, which were       
compared to the fine-tuning of the 8 BERT variants. 
4  Results and Discussion 
4.1  Sentiment Classification  
The first comparison shown is the sentiment task        
based on the Drugs.com dataset. We see that the         
test set accuracy is best with the use of fine-tuning          
BERT (Table 5). In all cases, each variant of BERT          
when it is fine-tuned, outperforms each of our        
baseline evaluation methods (Table 4). We see that        
BERT embeddings with LR outperformed ELMo      
embeddings with LR as expected. While the       
guidance for 2-4 epochs of training was explored,        
we saw continual performance improvement across      
all 8 different models when training with 4 epochs.         
There was no marked performance difference      
between BERT Cased, BioBERT, or Clinical      
BERT. However, there was reduced performance      
with the use of the BERT Uncased model. 
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Model Test Accuracy 
Most Common Class 0.602 
N-Gram + NB 0.890 
ELMo + LR 0.709 
Pretrained B-C + LR 0.720 
Table 4: Test accuracy of baseline models for 
sentiment classification 
Model 1 
Epoch 
2 
Epochs 
3 
Epochs 
4 
Epochs 
B-C 0.824 
(0.440) 
0.851 
(0.421) 
0.876 
(0.448) 
0.888 
(0.510) 
B-U 0.805 
(0.483) 
0.820 
(0.496) 
0.824 
(0.628) 
0.841 
(0.737) 
BB-1.0 0.824 
(0.444) 
0.854 
(0.415) 
0.877 
(0.445) 
0.887 
(0.504) 
BB-1.1 0.824 
(0.442) 
0.854 
(0.416) 
0.877 
(0.448) 
0.877 
(0.492) 
CB-A 0.821 
(0.445) 
0.854 
(0.415) 
0.877 
(0.459) 
0.888 
(0.515) 
CB-D 0.824 
(0.444) 
0.855 
(0.414) 
0.874 
(0.456) 
0.889 
(0.529) 
CBB-A 0.822 
(0.446) 
0.855 
(0.419) 
0.873 
(0.452) 
0.889 
(0.521) 
CBB-D 0.823 
(0.444) 
0.855 
(0.416) 
0.876 
(0.460) 
0.888 
(0.530) 
Table 5: Test set accuracy (and loss) from a variety 
of BERT fine-tuning for sentiment classification 
Because we saw increasing performance in the       
fine-tuned BERT models from 1-4 epochs, we also        
explored the effect that additional training could       
have on the model’s accuracy. For the ​CB-D model​,         
we saw improved performance at 10 epochs with a         
test accuracy of 0.906 and test loss of 0.693. Due to           
time and hardware constraints, we did not perform        
training across all 8 different models. 
The CB-D model fine-tuned with 4 epochs had        
misclassified 5,979 (11.1%) of the reviews. Of       
those that were misclassified, 5,252 (87.8%) were       
misclassified from negative or positive sentiment to       
neutral sentiment, and vice versa. From the       
remaining misclassifications, 390 (6.5%) reviews     
were misclassified as positive sentiment when      
labeled as negative sentiment (false positives), and       
337 (5.6%) reviews were misclassified as negative       
sentiment when labeled as positive sentiment (false       
negatives). A random sample of 50 false negatives        
and 50 false positives were analyzed. The majority        
of false negative reviews, 62%, had mentioned       
negative side effects, although the user rated the        
drug highly, while another 22% of reviews had        
mentioned a different drug than the one being rated.         
Of the false positive reviews, 40% had mentioned a         
different drug and 34% had mixed sentiment. 
4.2  Presence of ADR Classification 
A selection of BERT models were fine-tuned with 3         
epochs across 3 variants of the training data set         
(Table 6). We find that fine-tuning B-C, B-U, and         
CBB-D models were able to improve the F-scores        
from the baseline N-Gram with NB model. An even         
larger improvement was seen using BERT extracted       
features with CNN and LSTM models.  
Model Im- 
balanced 
Over- 
sampled 
Under- 
sampled 
Most Common 0 
(0.890) 
0 
(0.890)  
0 
(0.890)  
N-Gram + NB 0.197 
(​0.898) 
0.324 
(0.885) 
0.408 
(0.888) 
B-C 0.570 
(0.908 ) 
0.464 
(0.903) 
0.487 
(0.854) 
B-U 0.590 
(0.910)  
0.476 
(0.908) 
0.546 
(0.841) 
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CBB-D 0.544 
(0.902) 
0.523 
(0.912) 
0.510 
(0.820) 
B-U features + 
LR 
0.562 
(0.916) 
0.463 
(0.905) 
0.786 
(0.950) 
B-U features + 
CNN 
0.655 
(0.932) 
0.720 
(0.945) 
0.951 
(0.989) 
B-U features + 
LSTM 
0.978 
(0.995) 
0.995 
(0.999) 
0.995 
(0.999) 
Table 6: Test set F-score (and accuracy) from 
BERT fine-tuning and models for presence of ADR  
The BERT models seem to handle the imbalanced        
dataset with some success, as the models fine-tuned        
with the imbalanced dataset performed better in       
F-score compared to the oversampled and      
undersampled datasets. However, using the     
undersampled training dataset resulted in the best       
test set F-scores when using BERT extracted       
features and an additional classifier. 
4.3  ​Named Entity Recognition of ADRs 
We fine-tuned the 8 different BERT models with 3,         
5, and 10 epochs (Table 8) and compared these         
results to the baseline models (Table 7). We saw         
improved accuracy with BERT when compared to       
the two baseline models, with the highest       
performing model being the B-U model with an        
F-score of 0.72. This was surprising for an NER         
task, as typically cased information can be helpful        
in distinguishing entities. However, tweets do not       
follow the same formalities as the general written        
language, and can be frequently seen in all        
lowercase letters. 
Model F-score Accuracy 
Most Common Class 0.324 0.948 
CRF 0.502 0.951 
Table 7: Test set F-score macro and accuracy of 
baseline models for NER of ADRs 
Model 3 Epochs 5 Epochs  10 Epochs 
B-C 0.652 
(0.958) 
0.687 
(0.960 
0.687 
(0.961) 
B-U 0.549 
(0.960) 
0.684 
(0.960) 
0.720 
(0.965) 
BB-1.0 0.489 
(0.955) 
0.663 
(0.959) 
0.696 
(0.962) 
BB-1.1 0.521 
(0.953) 
0.661 
(0.959) 
0.652 
(0.956) 
CB-A 0.546 
(0.958) 
0.641 
(0.951) 
0.662 
(0.958) 
CB-D 0.546 
(0.955) 
0.685 
(0.959) 
0.681 
(0.961) 
CBB-A 0.602 
(0.961) 
0.619 
(0.955) 
0.646 
(0.959) 
CBB-D 0.556 
(0.958) 
0.647 
(0.952) 
0.649 
(0.956) 
Table 8: Test set F-score macro (and accuracy) 
from a variety of BERT models for NER of ADRs 
Of the words that were predicted as O but labeled as           
B or I (false negatives), the most frequent words         
were “of” and “out”. In the same vein, the most          
frequent words being predicted as B or I but labeled          
as O (false positives) were “my” and “me”. Because         
many of the ADR phrases contain prepositional or        
possessive words, such as in “sick to my stomach”,         
“messed up my attitude”, or “3 days of hell”, these          
words can be difficult for a classifier to distinguish.         
Notably, many ADRs are not described with any        
scientific or medical terminology. In some cases,       
adjectives such as “zombified”, “dopey” and      
“crazy” were used. The presence of colloquial       
language is reflected in the results from BioBERT        
and ClincalBERT, as these models actually      
performed worse compared to regular BERT for       
this task.  
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5  Conclusion 
We can see that while there exist a variety of          
different BERT variants that have been trained for        
specialized tasks, their generalizability may be      
limited when applied to a slightly different domain.        
While our expectation would have been for superior        
performance of both BioBERT and Clinical BERT       
in comparison to regular BERT, we did not see that          
this was the case. Although pharmacovigilance is       
within the scientific and medical domain, the 3        
tasks we tackled used data generated from patients        
who may not necessarily use the same language as         
scientists and healthcare providers.  
Regardless of the BERT variant, it appeared that        
fine-tuning for a larger number of epochs, 5 or 10          
epochs in comparison to the recommended 2-4       
epochs, had better performance on the test data for         
sentiment classification and NER. Furthermore, the      
use of an additional classifier on top of BERT         
extracted features can provide great benefit,      
especially when the dataset is limited in size, as         
shown for ADR classification. 
When tackling any related language model task, it        
can still be worthwhile to explore pre-trained BERT        
variants to determine an appropriate starting point       
prior to fine-tuning. BERT demonstrates its      
flexibility with competitive performance across all      
3 different tasks and 2 datasets. Fine-tuning BERT        
is a powerful tool to be utilized on many natural          
language processing tasks. 
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